Application of gnrh type Ⅱ antagonists in inhibiting the proliferation of progesterone-resistant endometrial cancer cells
A technology for endometrial cancer and endometrium, which is applied in the direction of antineoplastic drugs, drug combinations, and pharmaceutical formulations, and can solve problems such as downregulation of PR expression and progesterone resistance in endometrial cancer
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] Example 1. Application of GnRH antagonists in inhibiting Ishikawa and Ishikawa-MPA cell proliferation
[0050] Cell lines in this example: Ishikawa-MPA cells and Ishikawa cells.
[0051] GnRH antagonists in this example: Cetrorelix and Trptorelix-1.
[0052] 1. Plank
[0053] (1) When the Ishikawa (ISK) and progesterone-resistant cell line (ISK-MPA) cells grow to the logarithmic phase, inoculate a 96-well plate;
[0054] (2) Use 0.25% trypsin solution (0.25g trypsin and 0.02g EDTA dissolved in 100ml PBS solution) to digest each cell in step (1) respectively, and then use DMEM-F12 high glucose containing 10% FBS The medium was digested and blown to make a single cell suspension, and 10 μl of the single cell suspension was counted with a cell counting plate, diluted with DMEM-F12 high glucose medium containing 10% FBS, so that the final concentration of each cell was 5000 cells / ml, add 100μl to each well;
[0055] (3) 5 duplicate wells for each type of cells, and 7 96...
Embodiment 2
[0068] Example 2. Application of GnRH antagonists in inhibiting xenograft tumors in nude mice
[0069] 1. Experimental materials
[0070] Ishikawa (ISK), progesterone-resistant cell line (Ishikawa-MPA), recipient animals 5-6 weeks old BALB / C genetic background female nude mice.
[0071] 2. Establishment of xenograft tumor model in nude mice
[0072] 1. Take endometrial cancer cells (Ishikawa, Ishikawa-MPA) in the logarithmic growth phase and prepare them into single cell suspensions (5×10 6 cells were suspended in 0.5ml of normal saline), to obtain Ishikawa single-cell suspension and Ishikawa-MPA single-cell suspension respectively;
[0073] 2. Under sterile conditions, the Ishikawa single-cell suspension and the Ishikawa-MPA single-cell suspension prepared in step 1 were respectively inoculated subcutaneously on the shoulders and backs of the bilateral forelimbs of five 5-6-week-old BALB / C genetic background female nude mice ( Each cell was inoculated with 5 mice);
[007...
Embodiment 3
[0090] Embodiment 3, the impact of GnRH antagonists on PR mRNA and GnRHR mRNA expression levels in different cell lines
[0091] Cell lines used in this example: Ishikawa (ISK), progesterone-resistant cell lines (Ishikawa-MPA, ISK-MPA). GnRH antagonists used in this example: Cetrorelix and Trptorelix-1.
[0092] 1. Plank
[0093] (1) When the Ishikawa (ISK) and progesterone-resistant cell line (ISK-MPA) cells grow to the logarithmic phase, inoculate a 96-well plate;
[0094] (2) Use 0.25% trypsin solution (0.25g trypsin and 0.02g EDTA dissolved in 100ml PBS solution) to digest each cell in step (1) respectively, and then use DMEM-F12 high glucose containing 10% FBS The medium was digested and blown to make a single cell suspension, and 10 μl of the single cell suspension was counted with a cell counting plate, diluted with DMEM-F12 high glucose medium containing 10% FBS, so that the final concentration of each cell was 5000 cells / ml, add 100μl to each well;
[0095] (3) 5 ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com